Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

Breeze Hunter thought she had a lingering cold. When her symptoms got worse, she was diagnosed with a rare form of cancer: ...